ArticleThe Prostate2024

A pooled patient-reported outcomes analysis of moderately hypofractionated proton beam therapy and photon-based intensity modulated radiation therapy for low- or intermediate-risk prostate cancer.

Alexander Lukez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.